Neko Health, a Spotify founder's preventative-health startup, opened its first U.S. clinic. Plus, chemicals in natural-fiber clothing and the real culprit for childhood anxiety.
Spotify Technology S.A. (NYSE:SPOT) was last seen down 0.2% at $500.39, inching toward its fifth loss in the last six sessions. Furthermore, SPOT's most recent downturn has it crossing below the 200-day moving average, a familiar trendline of pressure.
Spotify is giving listeners a new tool to shape the recommendations it delivers to their app's Home feed.
Bank of America is standing firmly behind streaming giant Spotify Technology SA (NYSE:SPOT) despite a rough week for the stock. In a note Friday, the bank reiterated its Buy rating and $685 price target, pushing back against any narrative that the company's growth story is faltering.
Spotify (SPOT) closed the most recent trading day at $546.7, moving 2.07% from the previous trading session.
Spotify Technology NYSE: SPOT Co-CEO, Chief Product Officer and Chief Technology Officer Gustav Söderström outlined the company's strategy for using artificial intelligence, expanding into additional media formats and monetizing highly engaged users during an investor conference appearance.
Zacks.com users have recently been watching Spotify (SPOT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Spotify Technology S.A. (SPOT) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript
In the latest trading session, Spotify (SPOT) closed at $523, marking a -1.07% move from the previous day.
SPOT's Premium revenues rise 15% year over year to ???4.33B as subscriber growth and higher ARPU boost monetization, while ad revenues post gains.
Spotify (SPOT) reported earnings 30 days ago. What's next for the stock?
Spotify just posted its strongest fundamental quarter ever while its stock sits well below last year's peak, and that disconnect points to something worth paying close attention to before 2030.